Log in to save to my catalogue

Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in p...

Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_30449883

Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

About this item

Full title

Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Publisher

England

Journal title

Neuropsychopharmacology (New York, N.Y.), 2019-02, Vol.44 (3), p.598

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Dopamine D
receptor occupancy (D
RO) is a key feature of all currently approved antipsychotic medications. However, antipsychotic efficacy associated with high D
RO is often limited by side effects such as motor disturbances and hyperprolactinemia. Lumateperone (ITI-007) is a first-in-class selective and simultaneous modulator of serotonin...

Alternative Titles

Full title

Dopamine D 2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_30449883

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_30449883

Other Identifiers

E-ISSN

1740-634X

DOI

10.1038/s41386-018-0251-1

How to access this item